Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Nu-Med Plus's Total Stockholders Equity for the quarter that ended in Sep. 2024 was $-0.21 Mil. Nu-Med Plus's Total Assets for the quarter that ended in Sep. 2024 was $0.01 Mil.
The historical rank and industry rank for Nu-Med Plus's Equity-to-Asset or its related term are showing as below:
NUMD'
s Equity-to-Asset Range Over the Past 10 Years
Min: -200.3 Med: -1.64 Max: 0.84
Current: -29.29
During the past 13 years, the highest Equity to Asset Ratio of Nu-Med Plus was 0.84. The lowest was -200.30. And the median was -1.64.
NUMD's Equity-to-Asset is ranked worse than 99.31% of 868
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs NUMD: -29.29
Nu-Med Plus Equity-to-Asset Historical Data
The historical data trend for Nu-Med Plus's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Nu-Med Plus's Equity-to-Asset
For the Medical Devices subindustry, Nu-Med Plus's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nu-Med Plus's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nu-Med Plus's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Nu-Med Plus's Equity-to-Asset falls into.
Nu-Med Plus Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Nu-Med Plus's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nu-Med Plus (OTCPK:NUMD) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Nu-Med Plus Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of Nu-Med Plus's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Nu-Med Plus Inc is an medical device company principally engaged in the design, innovation, development, enhancement, and commercialization of beginning, early, and selective later-stage quality medical devices. It focuses on the formulation of Nitric Oxide powder, which is a desktop generator device which delivers inhaled Nitric Oxide to replace expensive pressurized canisters and a mobile rechargeable device to deliver inhaled Nitric Oxide gas to offer solutions to hospitals, health systems and medical community throughout the world.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NUMD has been successfully added to your 